Treace Medical Concepts, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, filed on May 23, 2023, details the results of the 2023 Annual Meeting of Stockholders held on the same date. Treace Medical Concepts, Inc. (TMCI) is a Delaware corporation listed on The Nasdaq Global Select Market.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results rather than financial performance.
Material Changes
No material financial changes are reported in this document. The primary event is the completion of the annual stockholder vote.
Management Commentary and Voting Results
Stockholders voted on two proposals:
- Proposal 1: Election of Directors. Three Class I directors were elected for a three-year term expiring in 2025.
- Lance A. Berry: 49,782,323 votes For; 2,624,816 Withheld.
- Elizabeth "Betsy" S. Hanna: 39,914,384 votes For; 12,492,755 Withheld.
- Jane E. Kiernan: 49,782,436 votes For; 2,624,703 Withheld.
- Proposal 2: Ratification of Auditor. Grant Thornton LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2023.
- Vote Count: 56,651,839 For; 5,348 Against; 29,343 Abstain.
Key Facts for Investor Verification
- Verify the specific reasons for the significant number of withheld votes (12.5 million) for director nominee Elizabeth "Betsy" S. Hanna compared to the other nominees.
- Confirm the total number of shares outstanding to calculate the percentage of votes cast for each proposal.
- Review the Definitive Proxy Statement (Schedule 14A) filed on April 4, 2023, for detailed background on the director nominees and auditor selection.